Opinion: Sizing Up GM Salmon

On the potential benefits and risks of genetically modified fish entering the marketplace

Written byTillmann Benfey
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA, NOAAMost farmed plants and animals are genetically different from their wild relatives as a result of domestication. From its beginnings through to the present day, this process has relied on the selection of individuals for breeding based on their expression of heritable characteristics such as disease resistance, faster growth, increased yield and, in the case of animals, improved feed conversion efficiency. The fact that such variation exists among individuals comes down to differences in their genomes and how these differences are expressed.

In the vast majority of cases, genetic variation among individuals arises from random events—most often mutations—over which breeders have no control. Typically, these random genotypic changes lead to decreased performance in agriculture and the culling of individuals from the population. Less frequently, but of critical importance, such changes can lead to improved phenotypes that can then be incorporated into breeding programs for genetic gain.

Working with random changes in the genomes of farmed plants and animals to make improvements in agriculture has served us well for thousands of years, but is a slow process.

What makes AquaBounty Technologies’ AquAdvantage Atlantic salmon unique among farmed animals is that its improved production characteristics (faster growth and improved feed conversion efficiency) are based on targeted changes to its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform